Xiaofeng M. Yao

Tianjin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

CAF-derived PAI-1 serves as an EGFR ligand and fuels KRAS-mutant pancreatic cancer.

CAF-derived PAI-1 serves as an EGFR ligand and fuels KRAS-mutant pancreatic cancer.

Journal: Nature communications

Published: May 29, 2025

Reprogramming tumor-associated macrophages and blocking PD-L1 via engineered outer membrane vesicles to enhance T cell infiltration and cytotoxic functions.

Reprogramming tumor-associated macrophages and blocking PD-L1 via engineered outer membrane vesicles to enhance T cell infiltration and cytotoxic functions.

Journal: Journal of nanobiotechnology

Published: January 04, 2025

Targeting STAT3 potentiates CDK4/6 inhibitors therapy in head and neck squamous cell carcinoma.

Targeting STAT3 potentiates CDK4/6 inhibitors therapy in head and neck squamous cell carcinoma.

Journal: Cancer letters

Published: March 27, 2024

Targeting IL-6/STAT3 signaling abrogates EGFR-TKI resistance through inhibiting Beclin-1 dependent autophagy in HNSCC.

Targeting IL-6/STAT3 signaling abrogates EGFR-TKI resistance through inhibiting Beclin-1 dependent autophagy in HNSCC.

Journal: Cancer letters

Published: November 10, 2023

The role of BHLHE40 in clinical features and prognosis value of PDAC by comprehensive analysis and in vitro validation.

The role of BHLHE40 in clinical features and prognosis value of PDAC by comprehensive analysis and in vitro validation.

Journal: Frontiers in oncology

Published: January 28, 2023

Application of next-generation sequencing in the pathogenesis of uveal melanoma

Application of next-generation sequencing in the pathogenesis of uveal melanoma

Journal: [Zhonghua yan ke za zhi] Chinese journal of ophthalmology

Published: November 09, 2022

Novel Insights of Anti-EGFR Therapy in HNSCC: Combined with Immunotherapy or Not?

Novel Insights of Anti-EGFR Therapy in HNSCC: Combined with Immunotherapy or Not?

Journal: Current oncology reports

Published: October 12, 2022

Clinical Significance and Prognostic Value of the Expression of LAG-3 and FGL1 in Esophageal Squamous Cell Carcinoma.

Clinical Significance and Prognostic Value of the Expression of LAG-3 and FGL1 in Esophageal Squamous Cell Carcinoma.

Journal: Bulletin of experimental biology and medicine

Published: August 03, 2022

A retrospective study of papillary thyroid carcinoma: Hashimoto's thyroiditis as a protective biomarker for lymph node metastasis.

A retrospective study of papillary thyroid carcinoma: Hashimoto's thyroiditis as a protective biomarker for lymph node metastasis.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: July 28, 2022

Integrative study reveals the prognostic and immunotherapeutic value of CD274 and PDCD1LG2 in pan-cancer.

Integrative study reveals the prognostic and immunotherapeutic value of CD274 and PDCD1LG2 in pan-cancer.

Journal: Frontiers in genetics

Published: July 09, 2022

Serum-derived extracellular vesicles mediate Smad4 expression through shuttling microRNA-27a in the progression of laryngeal squamous cell carcinoma.

Serum-derived extracellular vesicles mediate Smad4 expression through shuttling microRNA-27a in the progression of laryngeal squamous cell carcinoma.

Journal: Human cell

Published: November 02, 2021

Blockade of deubiquitinating enzyme PSMD14 overcomes chemoresistance in head and neck squamous cell carcinoma by antagonizing E2F1/Akt/SOX2-mediated stemness.

Blockade of deubiquitinating enzyme PSMD14 overcomes chemoresistance in head and neck squamous cell carcinoma by antagonizing E2F1/Akt/SOX2-mediated stemness.

Journal: Theranostics

Published: May 19, 2020

Showing 1-12 of 21

Last Updated: 09/26/2026